Mohamed Momtaz | Operations Research and Statistical Optimization | Editorial Board Member

Editorial Board Member

Mohamed Momtaz,
Tanta University.

Mohamed Momtaz
Affiliation Tanta University
Country Egypt
Scopus ID 57218249607
Documents 5
Citations 12
h-index 3
Subject Area Pharmaceutical industry
Event World Statistics Award
ORCID 0000-0003-4145-1863

Mohamed Momtaz is a researcher affiliated with Tanta University in Egypt, with a recorded research profile in the pharmaceutical industry. The supplied bibliometric information lists five documents, twelve citations, and an h-index of three. This article presents his available profile details in the context of academic recognition and research engagement. [1] [2]

Abstract

This article summarizes the supplied academic profile of Mohamed Momtaz, affiliated with Tanta University, Egypt, and associated with the pharmaceutical industry subject area. The profile records five research documents, twelve citations, and an h-index of three. Researcher identifiers and public profile links are provided for identification and further verification. The available information supports a concise overview of his academic record, while detailed publication titles, methods, and individual research findings require confirmation from the original bibliographic records.[1] [2]

Keywords

Mohamed Momtaz; Tanta University; Egypt; pharmaceutical industry; academic research; bibliometrics; scholarly publications; citation analysis; h-index; ORCID; Scopus author profile; World Statistics Award. [2] [4]

Introduction

Academic profiles help readers identify researchers, explore their scholarly activities, and understand their publication records. Mohamed Momtaz is affiliated with Tanta University in Egypt and is associated with the pharmaceutical industry subject area. His supplied bibliometric indicators provide a starting point for reviewing his research record. Further interpretation requires examining individual publications, research methods, and verified institutional information. [2]

Research Profile

The available profile identifies Mohamed Momtaz as affiliated with Tanta University, Egypt, and lists the pharmaceutical industry as his subject area. The supplied Scopus author identifier is 57218249607, while his ORCID provides an additional researcher identification reference. The reported record comprises five documents, twelve citations, and an h-index of three; these figures may change as databases update. [1] [2]

Research Contributions

The supplied information places Momtaz’s research profile within the pharmaceutical industry, a field involving medicine development, production, quality, regulation, and related analytical activities. However, the precise nature of his individual contributions cannot be established from bibliometric totals alone. Reviewing verified publication titles, abstracts, methods, and findings would help identify his research themes and distinguish individual contributions from collaborative work. [1] [2]

Publications

The supplied Scopus profile reports five documents associated with Mohamed Momtaz. These records provide a starting point for examining his scholarly output, collaboration patterns, and research topics. A complete publication bibliography should be prepared from verified database entries, with accurate author lists, publication dates, journal names, volume and page details, and DOI links where available. Individual titles and DOIs are not provided in the supplied information. [1] [3]

Research Impact

The supplied bibliometric indicators record twelve citations across five documents and an h-index of three. These measures offer limited quantitative perspectives on the visibility of a researcher’s publications, but they do not independently establish scientific quality, practical significance, or societal benefit. A fuller assessment would consider citation context, methodological rigor, reproducibility, collaborations, and evidence of application in pharmaceutical research or related practice. [1] [4]

Award Suitability

Mohamed Momtaz’s academic affiliation and recorded research activity provide information that may be considered during an academic recognition review associated with the World Statistics Award. His pharmaceutical industry subject area may be relevant where the award criteria encompass quantitative research or related analytical applications. Final suitability should depend on the specific award category, verified publications, documented contributions, and the official eligibility and evaluation criteria. [1]

Conclusion

Mohamed Momtaz’s supplied profile identifies an academic affiliation with Tanta University in Egypt and research activity associated with the pharmaceutical industry. The reported five documents, twelve citations, and h-index of three summarize selected bibliometric indicators. Further evaluation of his scholarly contributions requires verified publication records and contextual assessment. These details provide a foundation for profile documentation and a transparent academic recognition review. [1] [3]

References

  1. Elsevier. (n.d.). Scopus author details: Mohamed Momtaz, Author ID 57218249607. Scopus. Bibliometric figures in this article are based on the information supplied for the profile and should be checked against the current database record.https://www.scopus.com/authid/detail.uri?authorId=57218249607
  2. Momtaz, M. A., El-Desoky, H. S., & Abdel-Galeil, M. M. (2023). Ternary nanocomposite of activated charcoal/reduced graphene oxide-silver nanoparticles [ACH/Ag@rGO] as a novel platform for the first sensitive prucalopride drug detection in generic and innovator tablets and human plasma.

    https://doi.org/10.1149/1945-7111/ad048c

  3. Momtaz, M. A., El-Desoky, H. S., Rehab, A., & Belal, F. (2025). Quality-by-design optimized HPLC approach for the therapeutic drug monitoring of isosorbide dinitrate and sildenafil in human plasma samples.

    https://doi.org/10.1016/j.talo.2025.100540?utm_source=chatgpt.com

  4. Momtaz, M. A., El-Desoky, H. S., Rehab, A., & Belal, F. (2026). Evaluating the environmental sustainability of a stability-indicating HPLC method for the simultaneous quantification of ramipril and amlodipine besylate in pharmaceutical formulations and its application to content uniformity testing. Sustainable Chemistry and Pharmacy.

    https://doi.org/10.1016/j.scp.2025.102285?utm_source=chatgpt.com

Pratibha Pareek | Process capability index | Best Researcher Award

Dr. Pratibha Pareek | Process capability index | Best Researcher Award

Chandigarh group of colleges, Chandigarh college of technology, Mohali | India

Dr. Pratibha Pareek is an accomplished statistician and academician with specialized expertise in statistical quality control, statistical inference, Process capability index and reliability analysis. She holds a doctoral degree in statistical quality control from the Central University of Rajasthan, Ajmer, and has completed her postgraduate studies in statistics from the Central University of Punjab, Bathinda, with a strong academic foundation developed during her undergraduate education in mathematics, statistics, and computer applications at Panjab University, Chandigarh. Dr. Pareek is currently serving as an Assistant Professor at CGC Landran, Mohali, where she is actively engaged in teaching, research, and mentoring students in core and applied statistics. Her scholarly profile reflects a growing research impact, supported by peer-reviewed research documents, an emerging h-index, and increasing citations within the academic community. She actively participates in national and international academic events, including workshops and seminars focused on regression analysis, statistical optimization techniques, econometrics, and data-driven national development. Through her engagement with interdisciplinary statistical applications and software-based methodologies, Dr. Pareek continues to contribute meaningfully to research, education, and capacity building in statistics and data science, strengthening her role as a promising researcher and dedicated educator.

Citation Metrics (Google Scholar)

40
30
20
10
0

Citations
20

Documents
3

h-index
1

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications


Applications of reliability test plan for logistic Rayleigh distributed quality characteristic


M. Saha, H. Tripathi, A. Devi, P. Pareek – Annals of Data Science, 11(5), 1687–1703, 2024

Applications of process capability indices for supplier selection problems using generalized confidence interval


M. Saha, A. Devi, P. Pareek – Communications in Statistics: Case Studies, Data Analysis and Applications, 9, 2023

Time truncated attribute control chart for the generalized Rayleigh distributed quality characteristics and beyond


M. Saha, P. Pareek, H. Tripathi, A. Devi – International Journal of Quality & Reliability Management, 41(5), 1400–1416, 2024

Om Sambhaji Shelke | Operations Research and Statistical Optimization | Excellence in Research Award

Dr. Om Sambhaji Shelke | Operations Research and Statistical Optimization | Excellence in Research Award

Sinomune Pharmaceutical Co. Ltd | China

Dr. Om Sambhaji Shelke is a highly accomplished pharmaceutical scientist with extensive expertise in the formulation and development of topical, semisolid, solid, and liquid drug products. Holding a Ph.D. in Pharmacy and an M. Pharmacy from Savitribai Phule Pune University, he has over a decade of experience across global markets including the US, EU, China, Hong Kong, and India. Currently serving as Chief Scientist at Sinomune Pharmaceutical Co. Ltd. in Wuxi, Jiangsu, China, Dr. Shelke leads the development of generic topical products for the NMPA market. He is skilled in Quality by Design (QbD)-based development of creams, ointments, gels, shampoos, and solutions, with specialization in novel formats such as emulgel, organogel, nanogel, solid lipid nanoparticles, suspensions, and toothpaste. He also holds three granted patents and has published multiple scientific and technical articles. Throughout his career, he has received multiple awards recognizing his innovation, knowledge sharing, and leadership, including the StarFire Award. Dr. Shelke has held pivotal roles at leading pharmaceutical and consumer healthcare companies such as Prinbury Biopharm Co. Ltd., Encube Ethicals Pvt Ltd., Bright Future Pharmaceuticals Ltd., Unilever Industries Pvt Ltd., Abbott Healthcare Pvt Ltd., Dr. Reddy’s Laboratories, and Glenmark Pharmaceuticals Ltd., contributing to both regulatory-compliant NDA, ANDA, and 505(b)(2) products as well as OTC, cosmetic, and personal care formulations. His professional journey reflects a consistent commitment to scientific excellence, innovative product development, and leadership in cross-functional teams, positioning him as a prominent figure in global pharmaceutical research and development.

Profiles: Google Scholar | Orcid

Featured Publications

F. Jie, O. Shelke, Z. Yijie, C. Yulan, & L. Yongbo. (2025). Q1 and Q2 selection, Q3, IVRT, IVPT, pharmacokinetic and pharmacodynamic evaluation of topical generic product. Drug Development and Industrial Pharmacy, 51(6), 555–565.

J. Feng, O. S. Shelke, Y. Chen, Z. Zhang, X. Tang, & Y. Zhu. (2025). IVRT and IVPT of desonide lotion and cream: Correlation with human bioequivalence study. Journal of Pharmaceutical Innovation, 20(5), 196.

S. Krishna Phani Chandra, S. Om Sambhaji, & N. Shorgar. (2025). Quantification of leniolisib in rat plasma using LC-MS/MS: Method development, validation, and pharmacokinetic study. African Journal of Biological Sciences, 7(7), 121–142.

S. Om. (2025). Editorial article: The transformative impact of AI in pharmaceutical drug product development. Insights of Pharmatech, 1(2), 1.

S. Gadge, O. S. Shelke, R. Pingale, P. Palande, S. Tandale, P. Sonawane, … (2025). Development and evaluation of a polyherbal neem-based emulgel enriched with herbal oils for enhanced topical delivery and antibacterial efficacy. Journal of Chemical Health Risks, 15(3), 2189–2209.